COPD predicted to be third leading cause of death in 2030. WHO. 2008. Pdf:1–65.

Global Initiative for Chronic Obstructive Lung Disease. GOLD.2024. pdf : 1–218.

Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58.

Article  PubMed  PubMed Central  Google Scholar 

Ruvuna L, Sood A. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):315–27.

Article  PubMed  Google Scholar 

Mahmood T, Singh RK, Kant S, Shukla AD, Chandra A, Srivastava RK. Prevalence and etiological profile of chronic obstructive pulmonary disease in non-smokers. Lung India. 2017;34(2):122–6.

Article  PubMed  PubMed Central  Google Scholar 

Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D’souza GA, Gupta D, et al. A multi-centric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Ind J Chest Dis Allied Sci. 2006;48(1):23–9.

CAS  Google Scholar 

Stone RA, Lowe D, Potter JM, Buckingham RJ, Roberts CM, Pursey NJ. Managing patients with COPD exacerbation: does age matter? Age Ageing. 2012;41(4):461–8.

Article  PubMed  Google Scholar 

Leung JM, Obeidat M, Sadatsafavi M, Brandsma CA, Sin DD. The relationship between diabetes and COPD: lessons from a complex disease. Diabetes & Metabol J. 2018;42(3):224–32.

Google Scholar 

Meteran H, Backer V, Kyvik KO, Skytthe A, Thomsen SF. Co-morbidity between chronic obstructive pulmonary disease and type 2 diabetes: a nation-wide cohort twin study. Respir Med. 2015;109(8):1026–30.

Article  PubMed  Google Scholar 

Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of co-morbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80(2):112–9.

Article  PubMed  Google Scholar 

Lee CT, Mao IC, Lin CH, Lin SH, Hsieh MC. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study. Eur J Clin Invest. 2013;43(11):1113–9.

Article  PubMed  Google Scholar 

Roglic G. WHO Global report on diabetes: a summary. Int J Non-commun Dis. 2016;1(1):3–8.

Article  Google Scholar 

Pavord ID, Jones PW, Burgel PR, et al. Exacerbations of COPD. Int. J. Chron. Obstruct. Pulmon. Dis 2016;11 SI:21–30.

Classification and diagnosis of diabetes. Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(S1):S17–38.

Google Scholar 

Mahesh PA, Jayaraj BS, Prahlad ST, et al. Validation of a structured questionnaire for COPD and prevalence of COPD in rural area of Mysore: a pilot study. Lung India. 2009;26(3):63–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meteran H, Miller MR, Thomsen SF, Christensen K, Sigsgaard T, Backer V. The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms. Euro Resp J Open Res. 2017;3(4):00110–2017.

Google Scholar 

India State-Level Disease Burden Initiative CRDC. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1363–74.

Article  Google Scholar 

Mahishale V, Mahishale A, Patil B, Sindhuri A, Et A. Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India. Niger Med J. 2015;56(2):122–5.

Article  PubMed  PubMed Central  Google Scholar 

Ajit E, Bondade K, Rakesh J, Banur A, Raykar P. Prevalence of type 2 diabetes mellitus in chronic obstructive pulmonary disease and its impact on the severity of chronic obstructive pulmonary disease among patients attending tertiary care center in central Karnataka. Davangere Ind J Respir Care. 2019;8(1):42–5.

Article  Google Scholar 

Chakrabarti B, Purkait S, Gun P, et al. Chronic airflow limitation in a rural indian population: etiology and relationship to body mass index. Int J Chron Obstruct Pulmon Dis. 2011;6:543–9.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed MS, Neyaz AN, Aslami A. Health-related quality of life of chronic obstructive pulmonary disease patients: results from a community based cross-sectional study in Aligarh, Uttar Pradesh. India Lung India. 2016;33(2):148–53.

Article  PubMed  Google Scholar 

Sinha B, Singla R, Chowdhury R. An epidemiological profile of chronic obstructive pulmonary disease: a community-based study in Delhi. J Postgrad Med. 2017;63(1):29–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, et al. Chronic obstructive pulmonary disease, asthma and risk of type 2 diabetes in women. Diabetes Care. 2004;27(10):2478–84.

Article  PubMed  Google Scholar 

Song Y, Klevak A, Manson JE, Buring JE, Liu S. Asthma, chronic obstructive pulmonary disease and type 2 diabetes in the Women’s Health Study. Diabetes Res Clin Pract. 2010;90(3):365–71.

Article  PubMed  PubMed Central  Google Scholar 

Leung JM, Chen VL, Hollander Z. Elevated IL-1β levels are associated with an increased risk of developing diabetes in COPD patients. Int J Chronic Obs Pulmon Dis. 2018;2018(13):3491–7.

Google Scholar 

Bonaventura A, Montecucco F. Steroid-induced hyperglycemia: an underdiagnosed problem or clinical inertia? A narrative review. Diabetes Res Clin Pract. 2018;139:203–20.

Article  CAS  PubMed  Google Scholar 

Herth FJ, Bramlage P, Muller-Wieland D. Current perspectives on the contribution of inhaled corticosteroids to an increased risk for diabetes onset and progression in patients with chronic obstructive pulmonary disease. Respiration. 2015;89(1):66–75.

Article  CAS  PubMed  Google Scholar 

O’Byrne PM, Rennard S, Gerstein H, Radner F, Peterson S, Lindberg B, et al. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. Respir Med. 2012;106(11):1487–93.

Article  PubMed  Google Scholar 

Slatore CG, Bryson CL, Au DH. The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am J Med. 2009;122(5):472–428.

Article  CAS  PubMed  Google Scholar 

Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kinney G, Baker E. Type 2 diabetes mellitus and chronic obstructive pulmonary disease: need for a double-pronged approach. 2014;4 4:307–310.